World Leader in Healthcare Products Distributes Web Content Across Multiple Websites in Multiple Languages to Doctors, Healthcare Professionals and Consumers

SUNNYVALE, California - August 22, 2001 - Interwoven Inc., (Nasdaq: IWOV), the leading provider of Content Infrastructure, today announced that Novo Nordisk A/S (NYSE: NVO), one of the world's leading providers of healthcare products to counter diabetes, hemophilia and growth hormone disorders, is using Interwoven's Content Infrastructure product suite for all new company Web content management and deployment. With offices in 68 countries, Copenhagen, Denmark-based Novo Nordisk is implementing Content Infrastructure, which enables parallel Web initiatives to provide simple and effective handling of all Web assets and textual information across multiple Websites in multiple languages.

"Site visitors to the Novo Nordisk Website are often chronically ill, which makes it vital that our Web content concerning disease information and treatments is updated, relevant and correct for every product, in every country and in every language," said Jens Holmstrup, vice president of eBusiness at Novo Nordisk. " Interwoven's Content Infrastructure product suite offers the capabilities that give us more control and consistency throughout our global Web communications, while also allowing our non-technical experts to easily contribute content to our Website."

A deciding factor in Novo Nordisk's selection of Interwoven's Content Infrastructure is its open architecture, which provides a best-of-breed software approach enabling compatibility with any existing software commitments contributing or distributing content, as well as its multi-language compatibility.

"Novo Nordisk's standardization on Content Infrastructure affirms Interwoven's strong position in the pharmaceutical market," said Jan-Inge Arvidsson, managing director of Interwoven Nordic. "Interwoven's hybrid architecture provides Novo Nordisk with the means to integrate and make the most of existing and legacy technology investments. This rewards Novo Nordisk with two primary benefits: first, they can reduce the overall cost of implementing their eBusiness strategies, and secondly, that they can deliver the desired, compelling Web experience for their customers and end users."

In April, Interwoven announced its new Content Infrastructure product suite, which includes products for content aggregation, content collaboration, content management, content intelligence, and content distribution. For more information, please see http://www.interwoven.com.tw/company/features/ci/.

Novo Nordisk is a focused healthcare company and the world leader in diabetes care. In addition, Novo Nordisk has a leading position in such areas as coagulation disorders, growth disorders and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society. With headquarters in Denmark, Novo Nordisk employs approximately 15,000 people in 68 countries and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADSs are listed on the New York Stock Exchange under the symbol "NVO". For further company information visit www.novonordisk.com.

Interwoven, Inc. (Nasdaq: IWOV) is the world's leading provider of Content Infrastructure software. Its content infrastructure product suite includes content aggregation, content collaboration, content management, content intelligence and content distribution. Its products are the de facto standard for over 700 Global 2000 companies including British Airways, Cisco Systems, General Electric, General Motors and Philips. Interwoven teams with the leading best-of-breed eBusiness application providers to provide customers an end-to-end platform for eBusiness. For more information on one of the fastest growing software companies in Silicon Valley and its proven XML-based solutions, visit the Interwoven Web site at www.interwoven.com.tw.